Boule Diagnostics AB Stock Nasdaq Stockholm
Equities
SE0000437402
Advanced Medical Equipment & Technology
Sales 2024 * | 580M 53.15M 72.58M | Sales 2025 * | 620M 56.86M 77.64M | Capitalization | 381M 34.89M 47.64M |
---|---|---|---|---|---|
Net income 2024 * | 28M 2.57M 3.5M | Net income 2025 * | 41M 3.76M 5.13M | EV / Sales 2024 * | 0.79 x |
Net Debt 2024 * | 77.93M 7.14M 9.76M | Net Debt 2025 * | 75.63M 6.93M 9.47M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
9.09
x | Employees | - |
Yield 2024 * |
2.09% | Yield 2025 * |
3.47% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | 12-31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 20-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |